ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 734561 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 734561; 2) Community: the network communities that were significantly associated with the response to NSC 734561; 3) Molecule: the relationships between components within communities and NSC 734561; 4) MDR: the compounds that were significantly associated with the NSC 734561.

NSC Compound Enrichment Correlation
NSC 744469 3-cyano-3,3-diphenylpropyl 4-(3-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropyl)-1-piperazinecarbodithioate 0.0291420747327558 0.37938942
NSC 753790 6-Imino-1,2,3,4,8,9,10,11-octahydropyrido[1,2-a]pyrido[1',2',1,2]imidazo[5,4-f]benzimidazol-13-one 0.0291420747327558 -0.13752919
NSC 105132 Deoxycamptothecin 0.029142074732756 0.31166568
NSC 113423 NSC 113423 0.029142074732756 -0.083572688
NSC 178248 Chlorozotocin 0.029142074732756 0.32393045
NSC 208885 Null 0.029142074732756 0.032847798
NSC 276361 1H-Pyrrole-3,4-dimethanol, 1-(4-butylphenyl)-2,5-dimethyl-, bis(methylcarbamate) (ester) 0.029142074732756 0.36013661
NSC 28608 Null 0.029142074732756 0.0097879068
NSC 295499 Camptothecin Derivative 0.029142074732756 0.37315493
NSC 330507 Tanespimycin 0.029142074732756 0.034959761
Total:47  Current:26    [First] [Prev] [Next] [Last]